At each 6-month visit, blood was collected: One gray-top tube was sent for drugs-of-abuse screening (~10 mL) and four purple-top BD vacutainer tubes containing K2-EDTA as the anticoagulant (Becton Dickinson & Co., Franklin Lakes, NJ) were used to collect blood from patients (~40 mL) for serum and PBMC isolation, as described [41 (link), 42 (link)]. From 5×106 PBMCs, genomic DNA and total RNA isolation was performed using a Qiagen (Venlo, Limburg, Netherlands) AllPrep DNA/RNA procedure as described by the manufacturer.
Free full text: Click here